B

케이바이오랩스

038530KOSDAQ생활용품 도매업

64.0 / 100

Reference Date: 2026-07-24

Financial Score25.0 / 40
News Sentiment20.0 / 25
Momentum7.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 7.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

KEBIO operates in two main sectors: bio-distribution of life science equipment and reagents, and ICT solutions including hardware, software, and IT services. Since acquiring CureBio's distribution division in 2021, the company has expanded its bio-distribution business, leveraging over 20 years of experience. Additionally, it is broadening its ICT offerings by developing IoT-based security solutions, such as large-scale integrated control systems and smart policing services, building on its expertise in video security technology.

Number of Employees

38people

Average Salary

49.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 12.054.0Point
PBR
0.18Industry Average 0.517.0Point

Half of industry avg (excellent)

ROE
-4.82Industry Average 0.060.0Point

Well below industry avg

Debt Ratio
0.33Industry Average 11.058.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲97.1% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲166.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -8.8% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 80

Detailed Momentum

52-week position5.0Point

52w mid range (45%)

Current 800Won52-week high 1,48252-week low 225
1-month return1.0Point

1m -7.19% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

9 totalPositive 1Neutral 8Negative 0
  • Neutral주식병합결정2026-07-16
  • Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-07-16
  • Neutral주식등의대량보유상황보고서(일반)2026-07-16
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-16
  • Neutral증권발행결과(자율공시)2026-07-14